Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales. Hodgson D, Koltai M, Krauer F, Flasche S, et al. Vaccine 2022;40:7151-7157.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hodgson D, Koltai M, Krauer F, Flasche S, et al. Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales. Vaccine 2022;40:7151-7157.
PMID: 36328884